Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixiang Lu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal for Immunotherapy of Cancer|November 17, 2024
Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysisXiaojie Liang, Yufan Wang, Baiwei Luo, et al.
Blood Cells, Molecules & Diseases|May 4, 2024
Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axisGuopan Yu, Xiaofan Chen, Weixiang Lu, et al.
Translational Lung Cancer Research|September 12, 2024
<i>LungPath</i>: artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinomaHaoda Huang, Zeping Yan, Bingliang Li, et al.
Clinical and Experimental Medicine|August 10, 2023
Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemiaWeixiang Lu, Guopan Yu, Yanlin Li, et al.
BJS Open|March 21, 2024
Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort studyHongsheng Deng, Jun Liu, Xiuyu Cai, et al.
The Lancet. Oncology|February 19, 2020
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaWenhua Liang, Weijie Guan, Ruchong Chen, et al.
International Journal of Cancer|October 12, 2024
Latent class analysis-derived classification improves the cancer-specific death stratification of lymphomas: A large retrospective cohort studyXiaojie Liang, Yuzhe Wu, Weixiang Lu, et al.
Annals of Hematology|August 23, 2025
The global, regional, and national burden of Non-Hodgkin lymphoma in 204 countries and territories and 811 subnational locations, 1990-2021: an update from the Global Burden of Disease Study 2021Tong Li, Xiaojie Liang, Bingyu Lin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 4, 2026
The Changing Landscape of Second Primary Malignancies in Multiple Myeloma: A SEER Population-Based Study Between Two Therapeutic ErasWeixiang Lu, Xiaoshan Huang, Shengyu Tian, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Characteristics of second primary malignancies following bispecific antibodies therapyXiaojie Liang, Baiwei Luo, Bingyu Lin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|November 17, 2024
Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysisXiaojie Liang, Yufan Wang, Baiwei Luo, et al.
Blood Cells, Molecules & Diseases|May 4, 2024
Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p/caspase3 axisGuopan Yu, Xiaofan Chen, Weixiang Lu, et al.
Translational Lung Cancer Research|September 12, 2024
<i>LungPath</i>: artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinomaHaoda Huang, Zeping Yan, Bingliang Li, et al.
Clinical and Experimental Medicine|August 10, 2023
Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemiaWeixiang Lu, Guopan Yu, Yanlin Li, et al.
BJS Open|March 21, 2024
Upfront surgery for stage IIIA/B non-small cell lung cancer: retrospective cohort studyHongsheng Deng, Jun Liu, Xiuyu Cai, et al.
The Lancet. Oncology|February 19, 2020
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaWenhua Liang, Weijie Guan, Ruchong Chen, et al.
International Journal of Cancer|October 12, 2024
Latent class analysis-derived classification improves the cancer-specific death stratification of lymphomas: A large retrospective cohort studyXiaojie Liang, Yuzhe Wu, Weixiang Lu, et al.
Annals of Hematology|August 23, 2025
The global, regional, and national burden of Non-Hodgkin lymphoma in 204 countries and territories and 811 subnational locations, 1990-2021: an update from the Global Burden of Disease Study 2021Tong Li, Xiaojie Liang, Bingyu Lin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|March 4, 2026
The Changing Landscape of Second Primary Malignancies in Multiple Myeloma: A SEER Population-Based Study Between Two Therapeutic ErasWeixiang Lu, Xiaoshan Huang, Shengyu Tian, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Characteristics of second primary malignancies following bispecific antibodies therapyXiaojie Liang, Baiwei Luo, Bingyu Lin, et al.
Pageof 3